New shot promises brighter, less dry skin – but does it work?
NCT ID NCT07179198
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests an injectable solution called Kytogen Defend (KIO021) to see if it safely improves dry skin and dull complexion on the face. About 500 adults with these skin concerns will either receive the injection or no treatment. The goal is to measure visible skin improvement over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- KIO021 (carboxymethyl chitosan injectable solution)
- What this could lead to
- If it works, this could offer a temporary, non-surgical option to improve facial skin dryness and dullness.
- What could go wrong
- This is an early-stage trial with no prior results, so the treatment may not work better than no treatment. Risks from injections include swelling, redness, or infection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SKIN QUALITY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.